FMR LLC - FUSION PHARMACEUTICALS INC ownership

FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 30 filers reported holding FUSION PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
FMR LLC ownership history of FUSION PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10,862,405
-50.4%
4,177,848
-10.8%
0.00%
-50.0%
Q2 2023$21,909,219
-37.9%
4,681,457
-50.0%
0.00%0.0%
Q1 2023$35,298,186
+316.3%
9,362,914
+247.8%
0.00%
+100.0%
Q4 2022$8,479,971
-7.5%
2,692,054
-11.6%
0.00%0.0%
Q3 2022$9,171,000
+13.3%
3,046,813
-6.3%
0.00%0.0%
Q2 2022$8,094,000
-68.0%
3,250,680
-0.0%
0.00%
-50.0%
Q1 2022$25,259,000
+87.5%
3,250,832
+0.6%
0.00%
+100.0%
Q4 2021$13,469,000
-47.3%
3,229,966
+0.1%
0.00%
-50.0%
Q3 2021$25,554,000
-0.7%
3,226,471
+1.3%
0.00%0.0%
Q2 2021$25,728,000
-23.5%
3,184,209
+1.5%
0.00%
-33.3%
Q1 2021$33,643,000
-8.5%
3,138,388
+0.3%
0.00%0.0%
Q4 2020$36,772,000
-2.1%
3,129,434
+0.1%
0.00%
-25.0%
Q3 2020$37,561,000
-29.3%
3,124,803
+2.8%
0.00%
-33.3%
Q2 2020$53,091,0003,038,9980.01%
Other shareholders
FUSION PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 2,973,744$24,028,0004.99%
Pivotal bioVenture Partners Investment Advisor LLC 1,598,377$12,613,0004.97%
Johnson & Johnson Innovation - JJDC, Inc. 3,670,516$29,658,0003.03%
Sio Capital Management, LLC 266,107$2,150,0000.53%
Orbimed Advisors 3,224,770$26,056,0000.26%
Perceptive Advisors 3,550,334$28,686,0000.19%
AlphaCentric Advisors LLC 71,500$578,0000.16%
Rock Springs Capital Management LP 948,327$7,662,0000.15%
TPG Group Holdings (SBS) Advisors, Inc. 2,551,794$20,618,0000.15%
Artal Group S.A. 750,000$6,060,0000.12%
View complete list of FUSION PHARMACEUTICALS INC shareholders